SS-31 is a mitochondria-targeting peptide that binds cardiolipin to stabilize mitochondrial membranes and improve bioenergetics.

Research Focus:

• Mitochondrial dysfunction studies
• Ischemia-reperfusion injury protection
• Neurodegenerative disease research
• Cellular energy metabolism enhancement

Sources:

Cardiolipin binding & mitochondrial protection (Nature Communications): https://www.nature.com/articles/ncomms1180

Clinical/translational review (Frontiers in Pharmacology): https://www.frontiersin.org/articles/10.3389/fphar.2020.00818/full

Ischemia-reperfusion protection (PNAS): https://www.pnas.org/doi/10.1073/pnas.0910585106

⚠️ Disclaimer: For research use only. Not intended for human consumption. This information is provided for educational purposes and has not been evaluated by the FDA.